首页> 外文期刊>Journal of Surgical Research: Clinical and Laboratory Investigation >A newly designed total implantable venous access device in rats for research with high efficiency and low cost
【24h】

A newly designed total implantable venous access device in rats for research with high efficiency and low cost

机译:一种新设计的大鼠全植入式静脉通路装置,用于高效率和低成本的研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background In this study, we introduced a newly designed totally implantable device for long-term vascular access in rats and compared its efficacy, related complications, and cost-effectiveness with conventional exteriorized jugular vein catheters. Methods Forty adult male Sprague-Dawley rats, weighing 250-300 g, were equally divided into two groups (I and II) and all underwent jugular vein catheterization surgery. The totally implanted device was used in group I and conventional exteriorized catheters were used in group II. The functionality of each catheter was checked every 3 d and evaluation included vascular accessibility, patency, and infection. The weight of the animal and microbial culture from the wound and tube were also monitored. We analyzed the cause of vascular access failure and complications, both mechanical and infectious, and compared related variables. Results The proportions of 9-d patency and 30-d patency in group I were 90% (18/20) and 75% (15/20), respectively, and in group II 80% (16/20) and 35% (7/20), respectively. There was a statistically significant difference in 30-d patency. The rats in group II were more liable to involve vascular access failure because of catheter dislodgment and had a higher infection rate (P = 0.001). Daily body weight gain was also greater in group I than in group II (2.46 ± 0.59 g/d versus 1.84 ± 0.96 g/d; P = 0.02). Conclusions This newly designed and totally implanted device substantially increases the success rate of long-term venous access compared with conventional methods. It reinforces the merits of the subcutaneous port and a tethered swivel system and overall has better performance and reliability. Furthermore, given its low cost and the high level of effectiveness offered, this technology could be a powerful tool to be used in future translational medicine research, especially in cases of long-term intravascular administration.
机译:背景技术在这项研究中,我们引入了一种新设计的可完全植入的装置,用于大鼠的长期血管通路,并与传统的颈外静脉导管比较了其功效,相关并发症和成本效益。方法40只体重250-300 g的成年雄性Sprague-Dawley大鼠分为两组(I和II),均接受颈静脉导管插入术。第一组使用完全植入的设备,第二组使用常规的外部导管。每3天检查一次每个导管的功能,评估包括血管可及性,通畅性和感染。还监测了伤口和试管中动物和微生物培养物的重量。我们分析了机械和感染性血管通路衰竭和并发症的原因,并比较了相关变量。结果I组9d通畅率和30d通畅率分别为90%(18/20)和75%(15/20),而II组为80%(16/20)和35%(10/20)。 7/20)。 30天通畅率存在统计学差异。 II组的大鼠由于导管移位而更容易发生血管通路衰竭,并且感染率更高(P = 0.001)。第一组的每日体重增加也比第二组的大(2.46±0.59 g / d对1.84±0.96 g / d; P = 0.02)。结论与传统方法相比,这种新设计且完全植入的设备大大提高了长期静脉通路的成功率。它加强了皮下端口和系留式旋转系统的优点,总体上具有更好的性能和可靠性。此外,由于它的低成本和高水平的有效性,该技术可以成为将来转化医学研究中使用的强大工具,尤其是在长期血管内给药的情况下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号